A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer

NCT03522649 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

668

Enrollment

INDUSTRY

Sponsor class

Conditions

Previously Treated Metastatic Colorectal Cancer

Interventions

DRUG: Napabucasin
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Irinotecan

Sponsor

1Globe Health Institute LLC